The Gene Synthesis Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service (Antibody DNA Synthesis, Viral DNA Synthesis, Others), By Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, Others), By End-User (Biotechnology and pharmaceutical companies, Academic and government research institutes, Contract research organizations).
The gene synthesis market in 2024 caters to the growing demand for custom-designed DNA sequences and synthetic genes used in molecular biology research, genetic engineering, synthetic biology, and biotechnology applications, providing researchers, biotech companies, and academic institutions with cost-effective and efficient solutions for generating DNA constructs, gene variants, and genetically engineered organisms for basic research, drug discovery, and industrial bioprocessing. Gene synthesis involves the assembly of nucleic acid sequences using automated DNA synthesis platforms, enzymatic assembly methods, and gene editing tools such as PCR, Gibson assembly, and CRISPR-Cas9, enabling the generation of DNA molecules with precise sequence control, codon optimization, and functional modifications for applications ranging from gene cloning and protein expression to genome engineering and gene therapy. Market dynamics are driven by factors such as the increasing demand for synthetic biology tools and genetic engineering technologies, the growing adoption of gene synthesis services and DNA synthesis platforms, and advancements in DNA synthesis chemistry, oligonucleotide synthesis technologies, and gene editing techniques for rapid and scalable gene construction and custom DNA manufacturing. Collaboration between gene synthesis providers, biotechnology companies, and academic research laboratories drives innovation and market growth in gene synthesis, supporting more efficient gene design, DNA synthesis, and genetic manipulation for synthetic biology applications and biotechnological innovations.

A prominent trend in the Gene Synthesis market is the rising demand for synthetic biology applications across various industries. Synthetic biology involves the design and construction of novel biological systems or the redesign of existing biological systems for useful purposes. This trend is driven by the growing need for engineered biological components in areas such as pharmaceuticals, agriculture, biofuels, and industrial biotechnology. Gene synthesis plays a critical role in synthetic biology by enabling the custom design and construction of DNA sequences tailored to specific applications, driving market growth.
A key driver in the Gene Synthesis market is the continual advancements in DNA synthesis technologies. Over the years, significant progress has been made in DNA synthesis methods, including solid-phase synthesis, microarray-based synthesis, and enzymatic synthesis, leading to increased efficiency, accuracy, and scalability of gene synthesis processes. These technological advancements have resulted in faster turnaround times, higher synthesis yields, and reduced costs, making gene synthesis more accessible and affordable for researchers and industries alike, thereby fueling market expansion.
An opportunity for market growth in the Gene Synthesis market lies in offering customized gene synthesis services for personalized medicine applications. Personalized medicine aims to tailor medical treatment to the individual characteristics of each patient, including their genetic makeup. Gene synthesis can be utilized to engineer personalized therapeutic genes, gene editing tools, or gene delivery vectors for targeted therapies, gene therapies, and gene editing applications. By providing specialized gene synthesis services tailored to individual patient needs, companies can tap into the growing demand for personalized medicine solutions, offering new avenues for revenue generation and market expansion.
By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Services
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene & Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Biomatik
Boster Biological Technology
Brooks Automation Inc (GENEWIZ)
GenScript
Integrated DNA Technologies Inc
OriGene Technologies Inc
ProMab Biotechnologies Inc
ProteoGenix Inc
Thermo Fisher Scientific Inc
Twist Bioscience
*- List Not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Gene Synthesis Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Gene Synthesis Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Gene Synthesis Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Gene Synthesis Market Size Outlook, $ Million, 2021 to 2030
3.2 Gene Synthesis Market Outlook by Type, $ Million, 2021 to 2030
3.3 Gene Synthesis Market Outlook by Product, $ Million, 2021 to 2030
3.4 Gene Synthesis Market Outlook by Application, $ Million, 2021 to 2030
3.5 Gene Synthesis Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Gene Synthesis Market Industry
4.2 Key Market Trends in Gene Synthesis Market Industry
4.3 Potential Opportunities in Gene Synthesis Market Industry
4.4 Key Challenges in Gene Synthesis Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Gene Synthesis Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Gene Synthesis Market Outlook By Segments
7.1 Gene Synthesis Market Outlook by Segments
By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Services
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene & Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
8 North America Gene Synthesis Market Analysis And Outlook To 2030
8.1 Introduction to North America Gene Synthesis Markets in 2024
8.2 North America Gene Synthesis Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Gene Synthesis Market size Outlook by Segments, 2021-2030
By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Services
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene & Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
9 Europe Gene Synthesis Market Analysis And Outlook To 2030
9.1 Introduction to Europe Gene Synthesis Markets in 2024
9.2 Europe Gene Synthesis Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Gene Synthesis Market Size Outlook By Segments, 2021-2030
By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Services
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene & Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
10 Asia Pacific Gene Synthesis Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Gene Synthesis Markets in 2024
10.2 Asia Pacific Gene Synthesis Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Gene Synthesis Market size Outlook by Segments, 2021-2030
By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Services
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene & Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
11 South America Gene Synthesis Market Analysis And Outlook To 2030
11.1 Introduction to South America Gene Synthesis Markets in 2024
11.2 South America Gene Synthesis Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Gene Synthesis Market size Outlook by Segments, 2021-2030
By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Services
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene & Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
12 Middle East And Africa Gene Synthesis Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Gene Synthesis Markets in 2024
12.2 Middle East and Africa Gene Synthesis Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Gene Synthesis Market size Outlook by Segments, 2021-2030
By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Services
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene & Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Biomatik
Boster Biological Technology
Brooks Automation Inc (GENEWIZ)
GenScript
Integrated DNA Technologies Inc
OriGene Technologies Inc
ProMab Biotechnologies Inc
ProteoGenix Inc
Thermo Fisher Scientific Inc
Twist Bioscience
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Services
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene & Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Gene Synthesis Market is one of the lucrative growth markets, poised to register a 17.5% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Biomatik, Boster Biological Technology, Brooks Automation Inc (GENEWIZ), GenScript, Integrated DNA Technologies Inc, OriGene Technologies Inc, ProMab Biotechnologies Inc, ProteoGenix Inc, Thermo Fisher Scientific Inc, Twist Bioscience
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume